Open an account

Tactile Systems Technology

TCMD · NASDAQ

$23.52+$0.79 (+3.48%)TodayMarket closed ·
Prev close $22.73

About TCMD

Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 1,086 full-time employees. The company went IPO on 2016-07-28. The firm's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. The company is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. The company markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The company also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Employees
1,086
Headquarters
Minneapolis, Minnesota
Listed
Jul 28, 2016
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
tactilemedical.com

TCMD key statistics

Market cap
532.78M
Price-earnings ratio
21.05
Dividend yield
—
Average volume
216.33K
Volume
215.36K
Open price
$22.84
High today
$23.68
Low today
$22.84
52 Week high
$37.77
52 Week low
$14.46

Tactile Systems Technology (TCMD) at a glance

As of Oct 20, 2026, Tactile Systems Technology (TCMD) shares are priced at $23.52, giving the company a market cap of 532.78M and a price-to-earnings ratio of 21.05.

Today the stock has traded between $22.84 and $23.68. The current price is 3.0% above the day's low and 0.7% below its high.

Volume so far is 215.36K shares, in line with the average of 216.33K shares a day.

Over the past year Tactile Systems Technology has ranged from $14.46 to $37.77, and now sits 39% of the way up that range.

Tactile Systems Technology met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.34 per share against an estimate of $0.1469.

The average analyst price target is $39.78, 69.1% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $39.78
Low
$38.38
Now
$23.52
High
$42.00

TCMD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 45.9% on average.

  1. Q3 FY24: reported $0.21 per share against an estimate of $0.1814
  2. Q4 FY24: reported $0.40 per share against an estimate of $0.3201
  3. Q1 FY25: reported -$0.13 per share against an estimate of -$0.0714
  4. Q2 FY25: reported $0.14 per share against an estimate of $0.1102
  5. Q3 FY25: reported $0.36 per share against an estimate of $0.1775
  6. Q4 FY25: reported $0.46 per share against an estimate of $0.4488
  7. Q1 FY26: reported -$0.08 per share against an estimate of -$0.0959
  8. Q2 FY26: reported $0.34 per share against an estimate of $0.1469

TCMD news

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Tim Melvin

    10 Stocks That Prove Good Beats Perfect

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Vandana Singh

    Tactile Systems Stock Smashes 52-Week High After Strong Quarter

  • Insights into Tactile Systems Tech's Upcoming Earnings

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

Similar companies

Companies in the same industry as Tactile Systems Technology

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.